Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum

Pfizer Issued Warning Letter for Italian Manufacturing Plant

Company is notified of GMP violations at facility in Catania, Italy.
Apr 11, 2013

Company is notified of GMP violations at facility in Catania, Italy.

Navigating the Global Manufacturing Supply Chain

As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.
Apr 10, 2013

As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.

Pfizer Voluntarily Recalls Levoxyl

Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.
Apr 8, 2013

Company issues voluntary recall after learning of complaints of an uncharacteristic odor coming from Levoxyl bottles.

Eli Lilly Considers Investment in US Insulin-Manufacturing Capacity

Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.
Apr 8, 2013

Company considers investment in insulin cartridge-filling and insulin API manufacturing capacity in the US.

Indian Supreme Court Rejects Patent for Glivec by Novartis

Ruling has implications for intellectual property protection for innovator drugs in India.
Apr 3, 2013

Ruling has implications for intellectual property protection for innovator drugs in India.

The Plan by AstraZeneca CEO Pascal Soriot to Revitalize the Company

Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.
Apr 3, 2013

Restructuring and a strategic focus on three hubs in research and development are part of a plan to restart growth.

GlaxoSmithKline Tops Industry Rankings for Access to Medicines

The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.
Apr 3, 2013

The Access to Medicines Index shows that pharmaceutical companies are increasing drug development for the developing world and using more tiered pricing mechanisms to lower pricing.

Novartis Suffers Setback in Indian Patent Case for Glivec

Apr 2, 2013

Novartis loses an appeal in seeking patent protection in India for its anticancer drug.

Advancing Flow Chemistry in API Manufacturing

Continuous flow chemistry offers potential for greater control, improved safety and environmental profiles, and efficient chemical transformations.
Apr 2, 2013

Continuous flow chemistry offers potential for greater control, improved safety and environmental profiles, and efficient chemical transformations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here